This research study covers the two main segments in the European label-free
detection market: biochemical assays and cell-based assays. The revenue
forecasts for the Western European market for label-free detection for each
segment have been discussed, as have market share analyses by units and by
revenue. In addition, the technology roadmap, evolution of end-user base and
key applications of label-free detection have been analyzed. The study also
provides company profiles of the key market participants in addition to
discussing some key insights that have emerged from the end users about the
different companies, technologies and products.
Table of Contents
1. Executive Summary
European LFD Market
Executive Summary of European Market for LFD Systems
2. Research Methodology Scope and Segmentation
Objective Scope and Research Methodology
Research Methodology
Research Objective and Scope
Segmentation
3. Total Western European Market for Label-free Detection Systems
Total Market Overview
Introduction and Overview of LFD Technology
Evolution of End-user Bases in the LFD Market
Market Engineering Measurements
Application Overview of LFD
Technology Overview of LFD
Industry Challenges
Analysis of Impact and Duration of Drivers and Restraints
Revenue Forecasts
Market Share Analysis and Competitive Structure
SWOT Assessment
4. Company Profiles of Key Market Participants
Company Profiles
GE Healthcare/Biacore
Fortebio
Roche Applied Sciences
SRU Biosystems
Corning
Molecular Devices
Market Insights
5. Biochemical Assays Market
Biochemical Assays Market for LFD
Introduction and Market Overview
Market Engineering Measurements
Revenue Forecasts
Market Share Analysis by Units
Market Share Analysis by Revenues and Competitive Structure
6. Cell Based Assays Market
Cell-based Assays Market for LFD
Introduction and Market Overview
Market Engineering Measurements
Revenue Forecasts
Market Share Analysis by Units
Market Share Analysis by Revenues and Competitive Structure